A large study in the Journal of the American Medical Association indicated that prostate cancer screening has limited impact. The GRAIL-Galleri blood test shows promise in detecting cancer, though its accuracy varies across different cancer types. Various studies are exploring innovative approaches like saliva-based tests and nanoparticle technology.